Literature DB >> 29198662

Epidemiology and Risk Factors for Cancer After Lung Transplantation.

C Berastegui1, R LaPorta2, M López-Meseguer1, L Romero3, S Gómez-Ollés1, J Riera4, V Monforte5, B Sáez1, C Bravo5, A Roman6, P Ussetti2.   

Abstract

Cancer is the third most common cause of death among lung transplant (LT) recipients who survive for more than 1 year. The purpose of this study was to analyze the incidence and risk factors for cancer after LT in a Spanish cohort. The epidemiology and risk factors for cancer were retrospectively analyzed in LT recipients from 2 cities in Spain, Madrid and Barcelona. Of the 1353 LT patients initially included in the study, 125 (9.2%) developed cancer after a mean of 3.7 years. This frequency was 5-fold higher than in the general population. The most prevalent tumors were skin cancer (32%), lymphoproliferative disease (18%), and lung cancer (16.5%). In 4 patients, lung cancer was diagnosed on the day of the operation. The risk of cancer increased with age >55 year (hazard ratio [HR] 2.89 [1.64-5.09]; P < .001), in men (HR 2.8 [1.4-5.6]; P = .004), and in heavy smokers (>20 pack-years) (HR 2.94 [1.64-5.27]; P < .001). Other factors such as sun exposure were not found to be risk factors. In conclusion, prevalence of cancer is high in LT recipients in a Mediterranean country. Skin tumors, lymphoproliferative disease, and lung cancer are the most prevalent cancers. Age, male sex, and smoking were the main risk factors for cancer in this population.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2017        PMID: 29198662     DOI: 10.1016/j.transproceed.2017.09.043

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

2.  Robotic-assisted lobectomy after bilateral lung transplantation.

Authors:  Laura Romero-Vielva; Fernando Ascanio-Gosling; Anna González-Tallada; Joel Rosado-Rodríguez
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

3.  High prevalence of falsely declaring nicotine abstinence in lung transplant candidates.

Authors:  Tobias Veit; Dieter Munker; Gabriela Leuschner; Carlo Mümmler; Alma Sisic; Teresa Kauke; Christian Schneider; Michael Irlbeck; Sebastian Michel; Daniela Eser-Valerie; Maximilian Huber; Jürgen Barton; Katrin Milger; Bruno Meiser; Jürgen Behr; Nikolaus Kneidinger
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

Review 4.  Malignancy after lung transplantation.

Authors:  Osnat Shtraichman; Vivek N Ahya
Journal:  Ann Transl Med       Date:  2020-03

Review 5.  Lung Transplantation in Idiopathic Pulmonary Fibrosis.

Authors:  Rosalía Laporta Hernandez; Myriam Aguilar Perez; María Teresa Lázaro Carrasco; Piedad Ussetti Gil
Journal:  Med Sci (Basel)       Date:  2018-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.